These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4277496)

  • 1. Glucose tolerance in Down's syndrome.
    Sutnick AI; London WT; Gerstley BJ; Coyne VE; Blumberg BS; Lustbader ED
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):471-80. PubMed ID: 4277496
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility to leukemia: immunologic factors in Down's syndrome.
    Sutnick AI; London WT; Blumberg BS; Gerstley BJ
    J Natl Cancer Inst; 1971 Nov; 47(5):923-33. PubMed ID: 4256452
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in Down's syndrome. IV. Investigations on the "Xh" factor.
    Rittner C; Rittner B
    Clin Genet; 1973; 4(5):407-9. PubMed ID: 4270856
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis-B surface antigen among residents of an institution for the mentally retarded.
    Bruhl HH; Bauer H; Levy BS; Siem RA
    Minn Med; 1976 Apr; 59(4):263-7. PubMed ID: 131906
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Higgins GR; Parker CE; Faust JA; Rosenfeld M
    Am J Ment Defic; 1974 Jan; 78(4):426-8. PubMed ID: 4273154
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative mortality in mentally retarded patients in California, with and without Down's syndrome, 1986-1991.
    Singer RB; Strauss D
    J Insur Med; 1997; 29(3):172-84. PubMed ID: 10176367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose intolerance in the parents of children with Down's syndrome.
    Milunsky A
    Am J Ment Defic; 1970 Jan; 74(4):475-8. PubMed ID: 4244842
    [No Abstract]   [Full Text] [Related]  

  • 8. [Australia antigen in children with Down's syndrome].
    Korczowski R
    Pol Tyg Lek; 1972 Feb; 27(9):327-9. PubMed ID: 4259782
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytogenetic findings correlated with immune response to hepatitis virus B of institutionalized Down syndrome individuals.
    Smith A; Boughton CR; Hawkes RA; Schroeter DR
    Am J Ment Defic; 1982 Sep; 87(2):223-6. PubMed ID: 6214954
    [No Abstract]   [Full Text] [Related]  

  • 10. Fate of 14C-labelled tryptophan and 5-hydroxytryptophan in Down's syndrome.
    Airaksinen EM; Airaksinen MM; Pentikäinen P
    Ann Clin Res; 1973 Dec; 5(6):385-91. PubMed ID: 4275982
    [No Abstract]   [Full Text] [Related]  

  • 11. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
    Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
    Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australia antigen in Down's syndrome patients with Robertsonian translocation.
    Tevaluoto-Aarnio M; Hongell K
    Med Biol; 1974 Feb; 52(1):70-1. PubMed ID: 4283654
    [No Abstract]   [Full Text] [Related]  

  • 13. Gm antigenic titres in adults with Down's syndrome (mongolism), non-mongoloid mental defectives and healthy blood donors.
    Thom H; McKay E
    Clin Exp Immunol; 1972 Dec; 12(4):515-23. PubMed ID: 4265431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis-associated (Australia) antigen and Down's syndrome.
    Shiono H; Kadowaki J; Fujiwara T; Nakao T
    Clin Pediatr (Phila); 1975 Dec; 14(12):1150-4. PubMed ID: 127683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome.
    Sutnick AI; Oski FA; London WT; Millman I; Blumberg BS
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):3-8. PubMed ID: 4257700
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral hygiene in children with Down's syndrome.
    Pels E; Mielnik-Błaszczak M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):442-7. PubMed ID: 12898877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet autoimmunity in children with Down's syndrome.
    Gillespie KM; Dix RJ; Williams AJ; Newton R; Robinson ZF; Bingley PJ; Gale EA; Shield JP
    Diabetes; 2006 Nov; 55(11):3185-8. PubMed ID: 17065360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.
    Hawkes RA; Boughton CR; Schroeter DR; Decker RH; Overby LR
    Clin Exp Immunol; 1980 Jun; 40(3):478-86. PubMed ID: 6448112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to influenza vaccine in patients with Down's syndrome.
    Gordon MC; Sinha SK; Carlson SD
    Am J Ment Defic; 1971 Jan; 75(4):391-9. PubMed ID: 4251268
    [No Abstract]   [Full Text] [Related]  

  • 20. Occurrence of hepatitis B surface antigen in patients with Down's syndrome.
    Yüksel M; Uzunalimoğlu O; Oge G; Demirağ B
    Turk J Pediatr; 1977; 19(1-2):47-51. PubMed ID: 154756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.